ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 53 for:    Acorda

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis (M22)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01803867
Recruitment Status : Completed
First Posted : March 4, 2013
Last Update Posted : February 27, 2015
Sponsor:
Collaborator:
PRA Health Sciences
Information provided by (Responsible Party):
Acorda Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : January 2015